BOBBIE BUSETH: Open Payments
NPI 1740954494 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 16 payments from 7 companies in 2025. Trend: 2023 $313 · 2024 $643 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Alkermes, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: TRINTELLIX, Jornay PM, VRAYLAR, ARISTADA, INGREZZA, COBENFY, UZEDY, AUSTEDO XR.
Industry payments across ND — which companies pay providers there.
